A Dynamic Analysis of IRS-PKR Signaling in Liver Cells: A Discrete Modeling Approach by Wu, Ming et al.
A Dynamic Analysis of IRS-PKR Signaling in Liver Cells: A
Discrete Modeling Approach
Ming Wu
1., Xuerui Yang
2., Christina Chan
1,2,3*
1Department of Computer Science and Engineering, Michigan State University, East Lansing, Michigan, United States of America, 2Department of Chemical Engineering
and Material Science, Michigan State University, East Lansing, Michigan, United States of America, 3Department of Biochemistry and Molecular Biology, Michigan State
University, East Lansing, Michigan, United States of America
Abstract
A major challenge in systems biology is to develop a detailed dynamic understanding of the functions and behaviors in a
particular cellular system, which depends on the elements and their inter-relationships in a specific network. Computational
modeling plays an integral part in the study of network dynamics and uncovering the underlying mechanisms. Here we
proposed a systematic approach that incorporates discrete dynamic modeling and experimental data to reconstruct a
phenotype-specific network of cell signaling. A dynamic analysis of the insulin signaling system in liver cells provides a
proof-of-concept application of the proposed methodology. Our group recently identified that double-stranded RNA-
dependent protein kinase (PKR) plays an important role in the insulin signaling network. The dynamic behavior of the
insulin signaling network is tuned by a variety of feedback pathways, many of which have the potential to cross talk with
PKR. Given the complexity of insulin signaling, it is inefficient to experimentally test all possible interactions in the network
to determine which pathways are functioning in our cell system. Our discrete dynamic model provides an in silico model
framework that integrates potential interactions and assesses the contributions of the various interactions on the dynamic
behavior of the signaling network. Simulations with the model generated testable hypothesis on the response of the
network upon perturbation, which were experimentally evaluated to identify the pathways that function in our particular
liver cell system. The modeling in combination with the experimental results enhanced our understanding of the insulin
signaling dynamics and aided in generating a context-specific signaling network.
Citation: Wu M, Yang X, Chan C (2009) A Dynamic Analysis of IRS-PKR Signaling in Liver Cells: A Discrete Modeling Approach. PLoS ONE 4(12): e8040. doi:10.1371/
journal.pone.0008040
Editor: Timothy Ravasi, University of California San Diego, United States of America
Received September 18, 2009; Accepted October 12, 2009; Published December 1, 2009
Copyright:  2009 Wu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was supported in
part by the National Institute of Health (R01GM079688, R21CA126136, R21RR024439 and P42 ES004911), the National Science Foundation (DBI 0701709), and the
MSU Foundation and the Center for Systems Biology. M. W. is supported in part by Michigan State University (MSU) Quantitative Biology and Modeling
Fellowship.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: krischan@egr.msu.edu
. These authors contributed equally to this work.
Introduction
A major challenge in current molecular biology is to understand
the dynamic behavior of biological systems. Biological processes
consist of many interacting components, exceeding the human
capacity to systematically analyze them, thus requiring methods to
reduce the complexity and thereby enhance their accessibility [1].
Thus, a centralidea in systems biology is to construct models to help
reveal the design principles of biological systems [2]. Over the past
decade researchers have successfully identified genes and proteins
involved in many different signaling processes and assembled them
into pathways and networks. However, to use these interaction
maps to develop a detailed dynamic understanding of the functions
and behaviors that are specific to a biological system has yet to be
realized. Typically the pathways, networks and interaction maps in
the literature or databases are obtained from different cellular
systems and conditions, and may not be applicable to all systems
and under all conditions. Therefore it is unclearwhich pathways are
relevant to a particular system that is under investigation.
Here we proposed a systematic, dynamic analysis approach that
reconstructs a phenotype-specific network of cell signaling. As an
example, insulin signaling, a well-studied and complicated
signaling network, in mammalian cells is composed of branched
downstream signaling pathways and various feedback mecha-
nisms, which could benefit from modeling. In a separate study, our
group identified the involvement of a novel player, PKR, in the
insulin signaling network of HepG2 cells [3]. Previously known as
an immune response protein, PKR was found to be affected by
insulin, and more importantly, PKR modulated the upstream
mediators of insulin signaling, creating a feedback loop [3].
Considering the complexity of this insulin-PKR signaling network,
we applied modeling to unravel a context-specific, insulin-PKR-
signaling network, relevant to HepG2 cells, to obtain a better
understanding of the role of PKR in this complex signaling
network, and further to aid hypothesis-driven research on the
system dynamics.
A dynamic model that can efficiently integrate the literature
knowledge and experimental data [4] could provide valuable
working hypothesis to guide the experimental investigation [5,6].
Discrepancies arising between the simulation and experiment
could indicate potential missing or erroneous links that may lead to
new discoveries. In general, the approaches used to model the
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three categories, stochastic, kinetic, and discrete modeling.
Stochastic modeling captures the detailed reacting process of each
molecule in the system [7], kinetic modeling focuses on the
concentration change of the species [2], while discrete modeling
describes the general profile of a process evolving rather than the
time course of the molecules or species concentration. A major
advantage of discrete dynamic models, unlike detailed kinetic or
stochastic models, is that they do not require a complete set of
explicit biochemical or kinetic parameters in order to capture the
system dynamics [8]. This information is difficult to obtain for
most biological signaling processes [9], primarily because of the
diversity and complexity of the signaling network, the incomplete
knowledge of the regulatory mechanisms, and the lack of
quantitative time-series data [10]. Thus, discrete dynamic
modeling provides an alternative modeling approach, to test or
perturb a hypothetical regulatory network, in silico, to assess for
consistencies in the information accumulated on a particular
system by different experimenters under different conditions. [8].
Discrete Dynamic Modeling in Molecular Biology
Discrete dynamic or Boolean network modeling applies Boolean
algebra to obtain a qualitative, discrete representation of the
biological system [11]. A discrete model may associate logical
variables with gene expression or protein activity levels, and logical
functions with their biological relationships, such as transcription
regulation, protein-protein interactions, or biochemical reactions,
to characterize the system [9]. With the advent of genome-scale
maps of protein-protein interactions and transcription factor-DNA
binding data, available from different groups and through
databases, such as TRANSPATH (http://www.biobase.de),
BioCarta (www.biocarta.com), and STKE (www.stke.org), discrete
dynamic models can capitalize upon these resources to derive the
network architecture.
Discrete modeling has uncovered many important dynamic
features in biological systems. The dynamic model developed by Li
et al [12] captured the steady states corresponding to the different
biological cell-cycle phases in budding yeast. Further, discrete
modeling uncovered robust stationary states corresponding to real
biological events in the cell cycle of fission yeast [13], flower
morphogenesis [14] and floral cell-fate determination [8] in
Arabidopsis, and the segmentation pathways in Drosophila
development [15,16]. Despite these successes in revealing the
robust design of biological systems, discrete dynamic simulation is
still in its infancy with respect to generating predictions from
perturbation experiments. A recent discrete model of Arabidopsis
[17] predicted patterns of abscisic acid signal transduction and
identified key regulatory components. Here we applied a novel
discrete dynamic modeling approach using three-state logic
variables, taking into account cell-to-cell variations on the protein
activities and reaction rates, and allowing for simulated population
effects. As a proof-of-concept application of the discrete dynamic
model, we applied the methodology to insulin-PKR signaling in
liver cells. The model also provided testable hypothesis that were
experimentally validated.
Insulin Signaling Transduction in Liver Cells
Insulin is one of the major hormones controlling the complex
hepatic metabolic responses. Insulin binds to the insulin receptor
tyrosine kinase (IR), which recruits and phosphorylates the insulin
receptor substrate (IRS) proteins at tyrosine residues [18,19].
Upon tyrosine phosphorylation, the IRS proteins initiate, through
different binding mechanisms [20], various downstream signal
transduction cascades, including c-Jun N-terminal kinase (JNK)
[21,22] and phosphoinositide 3-kinase (PI3K) [23], which in turn
catalyze the formation of the lipid second messenger phosphati-
dylinositol-3,4,5-triphosphoate (PIP3). PIP3 may initiate the
downstream Akt/protein kinase B (Akt/PKB) [24], and atypical
protein kinase C (aPKC) [25]. In addition, IR can also
phosphorylate the SH2 domain of Shp2 protein, a tyrosine
phosphatase, and the SH3 domain of its adaptor molecule Grb2.
Activated Grb2 recruits Sos1 which, in turn, activates the MAPK
pathway mediated by the Ras protein.
Insulin signaling is tuned at the IRS level, by a large number of
regulators [26,27]. The activity of IRS is largely regulated by its
phosphorylation at the different residues. Tyrosine phosphoryla-
tion of IRS facilitates the recruitment of IRS substrates and
promotes insulin signaling [22], while the serine phosphorylations
generally suppress the activities of IRS by blocking the interaction
between IRS and IR [28], inhibiting the tyrosine phosphorylation
of IRS [29], or inducing the degradation of IRS [30]. A number of
serine residues have been identified to negatively regulate the
activity of IRS1, in particular, Ser307 (equivalent to Ser312 in
human IRS1). A number of signaling molecules, such as IkB
kinase (IKK) [31], mammalian target of rapamycin (mTOR) [32],
PKCf [33], S6 Kinase 1 (S6K1) [34], ERK [35] and JNK [36,37]
have been shown to function as IRS serine kinases that induce
insulin resistance by promoting the inhibitory phosphorylation of
IRS (reviewed in [26,38]). Research in our group has shown that
as one of the downstream target of insulin signaling, PKR is
intricately involved in regulating the insulin signaling process
through a feedback mechanism. The phosphorylaton of PKR is
down-regulated by insulin through the IRS-PI3K-AKT-PP1
pathway, and PKR inhibits insulin signaling by promoting the
phosphorylation of IRS at Ser312, through IRS serine kinases
such as IKK and JNK [3].
Given the complexity of insulin signaling, it is inefficient to
experimentally test all possible interactions in the network to
confirm their functionality. Thus, we proposed a novel discrete
dynamic network model that integrates potential interactions and
components of insulin signaling and its feedbacks in HepG2 cells.
Our simulations provided patterns of dynamic activation of each
component and generated testable hypothesis on the response of
the network upon perturbation, which were used to direct the
experiments.
Methods
Assumptions of Discrete Dynamic Model
1. Network architecture defines the major dynamic
characteristics. The dynamic behaviors are determined
primarily by the network architecture. This assumption is based
on the observation that biological systems tend to maintain their
functionality despite environmental and intrinsic noise that cause
fluctuations in their protein/RNA levels or reaction rates [39].
Many kinetic models based on differential equations show stable
patterns under a wide range of kinetic parameters, thus, we
hypothesize that the higher level abstraction of coarse-grained
discrete models can also successfully recover the major patterns of
the system. For example, a network of segment polarity regulation
in Drosophila development modeled by kinetic gene interactions
[40], was subsequently also successfully modeled using a Boolean
network model [15]. The Boolean model indeed was able to
reproduce the major patterns captured with a numerical method
approach, and correctly predicted some of the ectopic patterns
from the perturbation data (i.e., over-expression and mutant
studies). Similarly, differential equation- [41] and logic-based [42]
methods successfully modeled mammalian cell cycle progression
Dynamics of IRS-PKR Signaling
PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8040with a network consisting of the same central components. The
logic model was able to capture the dynamic features of the
system. These examples suggest that in many cases the dynamic
behavior of biological systems rely strongly on the network
architecture and more subtly on the kinetic parameters.
2. Discrete variables can represent the activity level of the
network components. In Boolean networks, the binary on/off
representations of mRNA or protein level, and the logical functions
for the interactions can be directly derived from qualitative
experimental data of activating/inhibitory role of the various
elements in the network. Since the switching behavior (i.e.,
activation/inhibition) is quick in many signal transduction
processes, it is reasonable to approximate the actual continuous
processofthe state of the network components with discrete levels [9].
3. Modularity. Given that modularity is a design principle of
biological systems [43], isolated or individual modules of the
system should be able to provide insight into the mechanisms that
govern the systems behavior or to mechanistically explain a
particular dynamic behavior of a system [14]. Therefore, we
assume that we do not need the entire network to gain mechanistic
insights. To investigate the role of PKR in insulin signaling of liver
cells, we include pathways mediated by IKK, JNK and ERK
because they have the potential, according to the literature or our
experiments, to mediate the interaction between PKR and IRS
(insulin signaling). We do not consider many of the other factors or
pathways involved in insulin signal, which may be regulated by
IKK, JNK or ERK but do not interact with PKR or feedback to
IRS. The same holds for the other intermediates (i.e., Raf, ShGS,
etc.). Our results show that this network module is able to provide
insight into the mechanisms that govern the system dynamics.
4. The building of the signaling network. The signaling
network can be formalized in terms of an oriented graph, where
the vertices represent the elementary components involved in the
process and the arcs describe the regulatory interactions between
those components. In the signaling network, each directed arc
reflects the direction of information flow from the source vertex to
its target in the signal transduction, and is labeled with a positive
or negative sign which defines activation or inhibition,
respectively. The network in Figure 1 was drawn with the
JDesigner in the SBW toolbox (www.systembiology.org).
5. The definition of the variables and initial states. We
represent the cell variation by the fluctuations in their initial
protein activity levels, which we assume to be a normal
distribution around a control state for each protein. We
associate each vertex in the signaling network with a discrete
variable, which has three states representing the activity of the
protein----0: lower than control, 1: the control state, 2: higher than
control. Thus by definition every component starts at the
‘‘control’’ state in the absence of insulin stimulation. We use a
discrete model with variables and transition rules (see below) to
represent the dynamic profile of a cell and we sample a large
population of cells. We choose an initial state for each regulatory
component from a distribution centered at the ‘‘control’’ state,
which reflects the cell-to-cell variation in the protein levels or
activities. The variation captured by the distribution represents the
degree of stochastic noise in the protein activities.
6. The definition of perturbation and noise. Constraints
are assigned to components to mimic the perturbations on the
network. If a protein is constantly inhibited (in an experiment), we
restrain the state of its corresponding variable in the model to be
always in either 0 (lower than control) or 1 (control state). Since we
apply a distribution on the initial states of the protein activity for
describing the cell-to-cell variation, we can use the variation over
the distribution of initial states to describe the degree of noise that
causes the cell-to-cell variation in the protein activities. Variation
in the cellular protein activity can lead to cell-to-cell variation [44]
that contributes, in part, to the noise in the system. Thus, the
model without any noise will start at the ‘‘control state’’ for every
protein and for each cell, whereas large amount of noise or
variation in the protein activity would manifest in many of the
proteins not being at their ‘‘control state’’ and varying from cell to
cell.
7. The specification of the state transition. We define
transition rules based on the activation/inhibition attributes on the
arcs in the signaling network. Two operations: shift up and shift
down adapted from the triple logic are applied in the model (see
Table 1). If an activator is in a state ‘‘higher than control’’, (e.g. the
kinase phosphorylation is increased), the state of its target will be
shifted upwards. In contrast, if the state of an inhibitor is higher
than control, its target will be shifted downwards in the next
updating event. For some components, there may be multiple
regulators that are active in one updating event and the
combinatory effect is determined by comparing the number of
activating to inhibitory factors. The target is shift-up if there are
Figure 1. Signaling network of insulin signaling and its
feedbacks. Each arc is assigned an attribute—either activation or
inhibition.
doi:10.1371/journal.pone.0008040.g001
Table 1. Shift up and shift down operations.
Shift up Shift down
Current-State Updated-State Current-State Updated-State
01 0 0
12 1 0
22 2 1
doi:10.1371/journal.pone.0008040.t001
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activating and inhibiting factors equal, we assume the target
remains at the control or current state. Finally, the state of a
component will decay if its regulators can no longer maintained
their active state.
In the simulation each run starts with its own set of randomly
generated initial states and a simulation result represents the
dynamic profile of a single cell in the population. By assuming that
cells response independently to a signal, we can simulate a large
number of independent runs to mimic a population effect and
measure the average evolving profile for the population (see
Figure 2).
Time is modeled by regular intervals called time-steps. Since
most components in our network are kinases or phosphotases, and
most reactions are protein phosphorylation and dephosphoryla-
tion, we assume that the duration of the activation/inhibitions and
the decay processes in the signaling transduction are comparable
and approximated by one time-step. Since the reaction rates may
be different from cell to cell even for the same interaction, we
apply asynchronous updating of the state, which is realized
immediately, rather than renewing every variable simultaneously
at each time-step. Thus, the relative rates of the different reactions
can be specified by the ordering of the update, which implies that,
although the response may be similar, the rate of response varies
from cell to cell. The rules for an asynchronous algorithm can be
written as: Sn
i ~fi S
m1
j1 ,S
m2
j2 ,...,S
ml
jk

,ml[ n{1,n fg where Sn
i is
the state of component i at time-step n, and fi is the transition
function associated with i and its regulators j1 to jk, and the time-
point corresponding to the last change of the regulators can be
either the last or current round of updates.
Since we embed the uncertainties in the signaling process by
applying random initial states and the asynchronous updating, we
need a population large enough to obtain a stable dynamic profile.
As shown in the graph (Figure S1), in a small population the
dynamic profile varies in different simulations due to the
embedded randomness, but in a large population the profile is
stable. Such behavior has been observed in real biological systems
where a single cell exhibits randomness while a large colony shows
an inherent and specific dynamics [45,46].
The dynamic model was implemented by custom MATLAB
code, with a random-order asynchronous updating algorithm,
which updates each component, one by one, in a randomized order
at each time-step, in each cell. The order in which the components
are updated is randomly chosen from a uniform distribution over all
possible permutations, to achieve random timing for each
regulatory interaction. As an example, let us consider a single
interaction: component A activates component B. Suppose A and B
are both in 1, the control state, but at the next time-step a stimulus
activates A and shifts its state to 2. If applying synchronous
updating, the state of B at this ‘‘next time-step’’ is 1 (since it is based
on the current state of A, which is 1), so B will be activated in the
following step, thus the time required for the activation from A to B
is fixed to one time-step. In asynchronousupdating,the state of B on
the next time-step is either 1 or 2 depending on whether the
updating of B is prior to the updating of A, which is randomly
chosen in a cell, thus the timing of the activation is variable. The
state-change process of this example is shown in Figure S2.
Experimental Materials and Methods
1. Cell culture and reagents. Human hepatoblastoma cells
(HepG2/C3A) were cultured in Dulbecco’s Modified Eagle
Medium (DMEM) (Invitrogen, Carlsbad, CA) with 10% fetal
bovine serum (FBS) (Biomeda Corp, Foster City, CA) and
penicillin-streptomycin (penicillin: 10,000 U/ml, streptomycin:
10,000 mg/ml) (Invitrogen, Carlsbad, CA). Freshly trypsinized
HepG2 cells were suspended at 56105 cells/ml in standard
HepG2 culture medium and seeded at a density of 106 cells per
well in standard six-well tissue culture plates. After seeding, the
cells were incubated at 37uC in a 90% air/10% CO2 atmosphere,
and two milliliter of fresh medium was supplied every other day to
the cultures after removal of the supernatant. The HepG2 cells
were cultured in standard medium for 5–6 days to achieve 90%
confluent before any treatment. Human insulin was purchased
from Sigma-Aldrich (St. Louis, MO), okadaic acid (OA), IKK
Figure 2. The simulation process of our discrete dynamic model.
doi:10.1371/journal.pone.0008040.g002
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(PD 98059) from EMD Biosciences (San Diego, CA).
2. Insulin treatment. Human insulin was stocked in HEPES
buffer, which was therefore used in controls for all the experiments
with insulin treatment. We treated the cells with insulin at
concentrations lower than 1 nM to mimic the physiological
concentrations [47]. At 95% confluence, cells were deprived of
serum for 16 hours prior to each experiment and subjected to
insulin treatment for the indicated doses and times at 37uCi n
serum-free medium.
3. Western blot analysis and immunoprecipitation.
HepG2 cells were lysed as described previously [48]. Total
protein levels were quantified by BCA assay kit from Pierce
Biotechnology Inc (Rockford, IL). 20–40 mg of total protein were
resolved by SDS-PAGE gels from Bio-Rad (Hercules, CA),
transferred to nitrocellulose membranes, and probed with primary
and secondary antibodies. Biotinylated protein ladders (Cell
Signaling, Beverly, MA) were loaded to one well of each SDS-
PAGE gel, and anti-biotin antibody was used to detect the protein
ladders on Western blots. Antibody detection was performed using
the enhanced chemiluminescence kit from Pierce Biotechnology
andimagedon the MolecularImagerChemiDoc XRS System from
Bio-Rad. Immunoprecipitation was performed as described
previously [48]. The western blots were quantified using the
Quantity One software (Bio-Rad). Phospho site-specific anti-IRS1
(Tyr941), anti-Akt (Thr308), and anti-Akt were purchased from
Abcam (Cambridge, MA), phospho site-specific anti-IRS1 (Ser312),
PKR(Thr451), anti-IRS1, anti-PKR, and anti-beta actin antibodies
from Sigma-Aldrich. Secondary anti-rabbit and anti-mouse
antibodies were purchased from Pierce Biotechnology Inc.
Results
We collected and integrated the literature information on
insulin signaling with emphasis on the different feedback pathways
and crosstalk with PKR and built a consensus regulatory network
that contained all the components and potential interactions (see
Method 1 and Figure 1). We formularized the signaling process
based on the network architecture into a discrete dynamic model
(see Method). By combining model simulations and experimental
validations, we identified the essential components and pathways
that function in our specific cell system.
Each simulation represented a single cell and we simulated a
large population to obtain an average pattern of the dynamic
activation of each component in the network, with or without
insulin stimulation. We compared the simulated and the
experimental profiles of IRS tyrosine, IRS serine, and PKR
phosphorylation levels.
The simulation result suggests plausible dynamic profiles of the
interacting network upon insulin stimulation, and based upon the
components and interactions potentially involved in our particular
cell system (Figure 1, see Introduction: Insulin signaling transduc-
tion in liver cells). The IRS and PKR activity are maintained in a
stationary state (control state) prior to insulin stimulation. Upon
insulin stimulation, the amount of tyrosine phosphorylated IRS
protein increases, followed by a decrease in the level of PKR
phosphorylation and the accumulation of the serine phosphory-
lated IRS protein. After some time, tyrosine phosphorylated IRS
downregulates or returns to basal levels, while the serine
phosphorylation of IRS remains elevated (Figure 3A).
Identification of Essential Pathways
Breakdown of the Akt-PKR loop: PP2A-Akt positive
feedback may not be involved. We designed several western
blot experiments to measure the changes in IRS tyrosine, IRS
serine, and PKR phosphorylation levels in response to insulin in
liver cells. The experimental results (Figure 3B) show an initial
increase in the IRS tyrosine phosphorylation upon insulin
stimulation, which is subsequently followed by an increase in
IRS serine phosphorylation accompanied with a decrease in IRS
tyrosine phosphorylation, likely due to the negative feedback
within the signaling network. This agrees with the predictions by
the dynamic model.
However, from the experiments, we observed that the PKR
phosphorylation decreases with the IRS tyrosine phosphorylation,
butratherthanremainingata constant,low levelaspredicted byour
model, PKR phosphorylation actually increases 15 minutes after
insulin stimulation (Figure 3B). Such discrepancy indicates poten-
tially incorrect connections in the network. Since the network is built
upon the current information obtained from different experimental
conditions and different groups, certain interactions may not
necessary be involved inorcontribute to the dynamicsof our system.
We then examined the contribution of each regulatory
interaction through in silico knockout experiments (Figure 4A
and Figure S3). Biologically ‘‘knockout’’ means removing or
mutating a particular gene in the genome to shut down its
expression, and thus one can investigate the outcomes to identify
the functional role of the gene that is knocked out. Here we
borrow the concept of ‘‘knockout’’ to describe our in silico
experiments of deleting a certain interaction to access its
contribution on the dynamics of the system. Thus, in our model,
by removing the interaction, we are suggesting that the pathway is
not active in our system. Further, it is not always necessary to
knockout the activity of a target to assess its role in a pathway;
reducing the activity can be sufficient to access the functional
contribution of an interaction and to experimentally evaluate
whether or not a prediction is valid. It appears that by either
deleting the PP2A-AKT or PKR-PP2A pathway, the PKR
phosphorylation profile then agrees with the experimental
observation. Further investigation into the literature on the
network architecture identified a local positive feedback module
involving AKT-PP1-PKR-PP2A (Figure S4) [3,49–52]. The
existence of such a local module would help to maintain a
continuous (persistent) activation of AKT, once stimulated, which
would lead to a continuous inhibition of the PKR signal.
Therefore, for the model to match the experimental results, this
positive feedback loop should not be active in the system. From the
literature, PKR is known to phosphorylate B56a, the regulatory
subunit of protein phosphatase 2A (PP2A), which then activates
the catalytic subunit of PP2A [51]. Indeed, previously we showed
that PKR induces the phosphatase activity of PP2A in HepG2 cells
[3]. Therefore the PKR-PP2A pathway should be present in the
network and the PP2A-Akt pathway should be excluded in order
to match the experimental dynamic profile of the PKR
phosphorylation in response to insulin.
It has been shown in different systems, but not in HepG2 cells,
that PP2A can induce the dephosphorylation of Akt at amino acid
residue Thr308, and thereby suppress the activity of Akt [53–55].
Therefore, we tested whether PP2A exploits any regulation on Akt
phosphorylation in HepG2 cells. Okadaic acid (OA) [56], a
specific PP2A inhibitor, with or without the simulation of insulin,
did not affect the phosphorylation of Akt at Thr 308 (Figure 4B).
This indicates that in our cell system, HepG2 cells, in response to
1 nM insulin, PP2A does not dephosphorylate Akt. Therefore, the
feedback from PP2A to Akt does not play a role in the signaling
network of HepG2 cells, which confirms the model prediction.
ERK feedback does not play a significant role. The in
silico knock-out results (Figure S3) show that many of the
Dynamics of IRS-PKR Signaling
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phosphorylation, such as mTOR-IRSS, S6K-IRSS, IKK-IRSS,
JNK-IRSS, ERK-IRS, if deleted, have no significant affect on the
dynamics of IRS tyrosine/serine and PKR phosphorylation levels.
This suggests these feedbacks may be redundant in the system.
Since we are trying to elucidate the regulatory role of our novel
component, PKR, in the insulin signaling network, we focused on
the IKK, JNK, and ERK mediated feedbacks, which directly
interact with PKR.
In order to elucidate the contribution of the different feedback
pathways, we evaluated topologies that contained only two of the
three pathways, JNK+IKK, ERK+JNK, and ERK+IKK, in
addition to the original topology containing all the ERK, JNK,
and IKK feedbacks (Figure 5A–D) to better assess which of these
kinases plays a role, and hence is non-redundant in our cell system.
We performed in silico perturbation studies on these 4 different
network architectures upon inhibition of JNK, IKK, or ERK, and
obtained the dynamic profiles of the IRS tyrosine/serine and PKR
phosphorylation levels, which was compared with the experimen-
tal results upon inhibition of IKK, JNK, or ERK (Figure 5E).
The experimental result shows the JNK inhibitor significantly
down-regulated the IRS serine phosphorylation and up-regulated
the IRS tyrosine phosphorylation, as compared with the normal,
unperturbed insulin stimulated network. Therefore, the model
Figure 4. Breakdown of the Akt-PKR loop. A) In silico knock-out.
For each subgraph, an interaction is deleted from the model and the
simulation is performed on the knock-out model. The interaction being
knocked out is labeled at the top of each subgraph in the form of ‘‘no’’-
regulator-target. Red line: IRS serine phosphorylation, green line: IRS
tyrosine phosphorylation, blue line: PKR phosphorylation. B) Western
blot: effect of PP2A inhibitor (OA, 2 nM [56]) on the phosphorylation of
Akt at Thr308. OA: Okadaic Acid.
doi:10.1371/journal.pone.0008040.g004
Figure 3. The simulated and experimental results of the PKR and IRS phosphorylation. A) Model simulations with or without insulin
stimulation. The simulation is on the initial model including the potential interactions and components from the literature and our experiments. The
interactions emphasized are the level of IRS serine phosphorylation (IRSS), IRS tyrosine phosphorylation (IRST), and the PKR phosphorylation. B) Time
series of the PKR and IRS phosphorylation upon insulin stimulation at time 0. HepG2 cells were exposed to 1 nM of insulin for 5, 10, 15, 30, or 60
minutes. After treatment, the cells were harvested, and western blot analysis was performed to detect the total and phosphorylated levels of PKR and
IRS1 [3]. The phosphorylation levels of PKR (blue) and IRS1 (red for p-IRS1 at Ser312 and green for p-IRS1 at Tyr941) were quantified and normalized to
the total protein levels of PKR and IRS1, respectively, and are expressed as the average of four samples6SD from four independent experiments.
doi:10.1371/journal.pone.0008040.g003
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IKK or ERK inhibitor does not have a significant effect on the
phosphorylations of IRS (Figure 5E). This is inconsistent with the
IRS phosphorylation profiles under JNK, IKK and ERK
inhibition predicted by the model containing all three pathways,
where the JNK and ERK inhibition have similar profiles
(Figure 5A). Therefore, we hypothesize that all three feedbacks
are not essential in the regulation of the IRS-PKR system.
Figure 5. Identification of essential feedback pathways through in silico perturbation study. Each column represents a different
architecture containing. A) Original ERK+JNK+IKK feedback pathways, B) Only with IKK+JNK feedback pathways, C) Only with ERK+JNK feedback
pathways, and D) Only with ERK+IKK feedback pathways. Row 1 the model simulation is performed without any perturbations. Row 2 the model
simulation is performed on IKK inhibition. Row 3 the model simulation is performed on JNK inhibition. Row 4 the model simulation is performed on
ERK inhibition. E) Western blot: effects of JNK, IKK and ERK inhibitors on the phosphorylation of IRS1 upon simulation with 1 nM insulin for 15 mins.
doi:10.1371/journal.pone.0008040.g005
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pathway (JNK+IKK) provided the most significant change in the
dynamic profiles of IRS phosphorylation upon JNK inhibition as
compared with that of the IKK inhibition (Figure 5B), as suggested
by the experimental results (Figure 5E, JNK vs. IKK inhibition).
Thus we hypothesize that the ERK feedback should not be
included in our insulin signaling network, which we confirmed
experimentally (Figure 5E, ERK inhibition). Although the
experimental results suggest that the IKK inhibition does not
affect the phosphorylation of IRS1 (Figure 5E), the simulation
suggests that removing the IKK feedback from the network would
give similar results upon JNK and ERK inhibition (Figure 5C),
which does not match the experimental results (Figure 5E). Thus,
we performed further perturbations to assess whether the IKK is
an essential pathway in the network.
Application of the simulation model in PKR over-
expression. To further evaluate which pathways are essential
in the dynamic model, we simulated the case of PKR over-
expression with the network topology model without the ERK
feedback to serine phosphorylation of IRS. Figure 6A shows that
PKR over-expression increased the Ser phosphorylation and
decreased the Tyr phosphorylation of IRS1, which is supported by
the experiments (Figure 6B comparing lanes 1 and 2). Next we
simulated the inhibition of IKK or JNK upon PKR-over-
expression in the model, and found that in both cases, the Ser
phosphorylation of IRS1 is decreased while the Tyr
phosphorylation was increased (Figure 6A). These model
predictions matched the experimental observations (Figure 6B).
As expected, inhibition (Figure 5) or silencing of ERK (Figure S5)
does not have any effect on the Ser and Tyr phosphorylations of
IRS1. Taken together, these results confirm the model predictions
and support the ability of the discrete dynamic model to predict
and guide experimental analyses. Interestingly, by comparing the
IKK inhibition (in the model and experiments) in the PKR over-
expression case, we found that IKK mediates the effects of PKR
on IRS1 phosphorylation, however, the basal level of IKK, if not
activated, does not play a significant role in regulating IRS1
phosphorylation. Therefore, the essential pathways involving IRS-
PKR signaling in our cell system is shown in Figure 7.
Robustness of the Signaling Network
We used the distribution of initial states to describe the cell-to-
cell variation of protein activity levels due to environmental or
endogenous noise. The variation over the distribution of initial
states represents the degree of noise. Multiple simulations were run
on the architecture consisting of the essential pathways, under
varying levels of noise, with and without insulin stimulation. The
simulation results (Figure 8) suggest the dynamics of insulin
signaling are very stable against the noise associated with variation
in the distribution of initial states or cell-to-cell variation. Such
robustness may arise from the multiple negative feedbacks within
the network, that help maintain a very stable, stationary state in
the absence of stimulation, and ensure specific signaling patterns
despite the uncertainties involved.
We further simulated the perturbation models under a different
noise level (e.g., uniform distributed initial states) and found the
dynamic profiles to be robust (Figure S6) and almost identical to
the previous simulation results where most (70%) of the cells
initiated from the control state. Thus, it is not likely that the
dynamic features discovered are artifacts of the modeling methods.
The robustness of the signaling network suggests the dynamics are
encoded in the architecture of the insulin-signaling network within
the cell system, and such robustness in the dynamics ensures a
robust transduction of insulin signaling.
Discussion
We enhanced the discrete modeling approach by extending the
on/off logic of traditional discrete Boolean models to a three-level
logic model with ‘‘high, control, low’’. Also, rather than assigning
ad-hoc absolute values as initial states, for each component we
defined its state prior to stimulation by a distribution centered on
the ‘‘control state’’ and compared the effect of the perturbation
with the control state, and thereby avoiding the problem of
defining the initial state in traditional Boolean network models.
In contrast to the traditional Boolean models that apply one
model to describe the whole process, we apply an individual model
to every single cell with each cell having a distinct initial state from
a distribution centered on the control state. The simulation
produces a response by obtaining the average effect of a large
group of cells. This modeling approach takes into account the
population effect and cell-to-cell variation, such that the resultant
model can capture the deviations or alterations from the control
state that is conceptually consistent with the western blot
experiments.
Limitations in Discrete Modeling
Lack of exact timing. Discrete dynamic models do not
represent or capture the exact timing, but the resultant dynamic
patterns provide a dynamic profile evolving with ‘‘time-steps’’,
which may contain artifacts due to the network reconstruction and
the updating rules at each time step. Previous biological Boolean
network models were simulated in such a way that all the
components changed their states simultaneously by one unit of
time, based on the assumption that every reaction in the network
takes exactly one unit of time in the signaling process. However, in
a real biological system, the reactions are not homogenous,
different reactions may have different rates, thus ‘‘synchronous’’
updating may not be appropriate. Klemm et al. [57] evaluated the
stability of attractors in Boolean networks and found that many
attractors disappear with slight perturbation in the time-steps,
suggesting that they may be artifacts due to the synchronous
updating.
Asynchronous updating has been suggested to reduce the
artifacts due to the assumption of uniformity in all the reactions
arising from synchronous updating [42,58]. In asynchronous
clocking, we update the state of each component one by one at
each time-step, and any state update is realized immediately and
will affect the other components’ state change, even within the
same time-step. In this way, some of the cells realize the updated
state immediately while other cells take longer to respond and
therefore do not update at the same time, thus leading to variable
reaction times/rates for each cell. We implemented asynchronous
updating in the modeling method (see Method) by randomly
generating the reaction order for each time step and in each
simulation. This allows us to take into account the uncertainty of
the reaction rates in different cells.
Even with asynchronous updating, there still may be artifacts
that arise due to the discrete timing, such as small fluctuations. For
example, a simple regulatory network with only three components
is shown in the Figure S7, where the simulation of a qualitative
model is compared with the result of a kinetic model. Figure S7
also shows that the artifacts in the synchronous updating would
significantly affect the correct prediction of the system dynamics.
Loss of subtle dynamics. Discrete models are based solely
on the qualitative relationships of the network elements, and thus
may lose certain subtle dynamics. It has been shown that in some
cases certain kinetic parameters are essential for a system’s
behavior (e.g., the reaction constants of phosphatases determine
Dynamics of IRS-PKR Signaling
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MAPK kinase cascade model in [59]), which cannot be captured
in qualitative models. The discrete models are essentially
simplifications of the kinetic equations in that the reaction laws
are reduced to a non-parametric form [60]. For example, the
actual reaction ‘‘ARB with kinetic constant k’’ may be considered
in the qualitative representation as ‘‘if A is high, B could be up-
regulated’’, but the effect of parameter ‘‘k’’ is neglected. Thus the
Figure 6. Application of the simulation model in PKR over-expression. A) In silico perturbation. Simulation of PKR over-expression and IKK or
JNK inhibition with PKR over-expressed. Simulations are based upon the model including the JNK and IKK pathways but without the ERK feedback. B)
Western blot results of the tyrosine and serine phosphorylation of IRS1 and the phosphorylation of PKR, after 15 mins of 1 nM insulin treatment,
when PKR is over-expressed in HepG2 cells, with or without the IKK/JNK inhibition. IKK and JNK restores Tyr and reduces Ser phosphorylation of IRS1
(red box), as compared to the control with PKR over-expressed (blue box).
doi:10.1371/journal.pone.0008040.g006
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parameters may (or may not) be captured as patterns of state-
change in discrete models, the latter provides only a rough
approximation of the real reaction system [10].
Since our insulin signaling network is somewhat homogenous
with only protein phosphorylations/dephosphorylations, our
model treats every interaction and feedback the same, and does
not take into account the different strength or time scale of the
interactions and feedbacks, which are possible in real systems,
especially in heterogeneous networks with both protein interac-
tions and transcription regulations. Nevertheless, as long as the
quantitative experimental data are available that captures such
differences, we can further adjust the model to integrate such
information, by increasing the discrete levels and applying more
subtle rules. For example, one can apply longer updating time for
transcription regulations than for protein interactions.
Advantages of Discrete Modeling
The advantage of discrete modeling is that only qualitative
information is required. Kinetic modeling (and stochastic
modeling) requires detailed kinetic parameters and initial concen-
trations for each component in the network, which is usually not
available for all the components in the network. Without the need
for kinetic parameters, the discrete modeling approach can model
and simulate larger networks, given the abundant qualitative
interaction maps of biological systems that are available.
Discrete dynamic modeling represents a higher abstraction of
biological network as compared with kinetic modeling, and
perturbations on the structure of the network are more easily
simulated with the discrete models. Kinetic approaches usually
perturb parameters of a system rather than the structure, because
a different set of kinetic parameters (and even different equations)
may be required if the network structure is changed. Therefore, it
is very difficult to obtain those parameters for the perturbed
system, despite the availability of experimental data.
As a simplified qualitative model, discrete dynamic model has
finite system-states, thus one can analyze the design principle of
the network structure by exploring all the possible states to find the
stationary ones [12]. Similar analysis is usually very difficult with
kinetic or stochastic models because the parameter space is too
large to sample thoroughly.
In conclusion, our novel modeling approach provides a
systematic description of the biological process, which enables
testable predictions that can serve as working hypothesis for
experimental evaluation. By combing modeling and experiments,
we can develop a hypothesis-driven framework that can be
iteratively refined to enhance our understanding of the insulin
signaling network dynamics in the context of a particular cell
system. Such a framework that relies solely on the network
architecture can be easily extended to other dynamic network
systems and serves as a basis to guide model-based experiments
and potentially more detailed inquiry into the regulatory
mechanisms of biological networks.
Supporting Information
Figure S1 With a small population the dynamic profile varies
significantly in the different simulations due to the embedded
randomness, whereas in a large population the profile is stable.
Found at: doi:10.1371/journal.pone.0008040.s001 (0.38 MB TIF)
Figure S2 An example of the implementation of synchronous
and asynchronous updating for a cell.
Found at: doi:10.1371/journal.pone.0008040.s002 (0.16 MB TIF)
Figure S3 In silico knock-out. For each subgraph, an interaction
is deleted from the model and the simulation is performed on the
knock-out model. The interactions being knocked out is labeled at
the top of each subgraph in the form of ‘‘no’’-regulator-target. Red
line: IRS serine phosphorylation, green line: IRS tyrosine
phosphorylation, blue line: PKR phosphorylation.
Found at: doi:10.1371/journal.pone.0008040.s003 (0.44 MB TIF)
Figure S4 A local positive feedback module from AKT to PP2A
Found at: doi:10.1371/journal.pone.0008040.s004 (0.07 MB TIF)
Figure S5 The effects of ERK silencing or inhibition on the
phosphorylation of IRS1 in PKR over-expressed cells. (A)
Reverse transfection of suspended HepG2 cells were performed
with scrambled siRNA (NC) or siRNAs of ERK1 and ERK2
together for 24 hours and the transfected cells were cultured in
regular media for another 24 hours. Next, the forward transfec-
tion of empty vector pCMV6-XL5 (pCMV6) or plasmid
containing PKR cDNA sequence (pCMV6-hPKR) was per-
formed, followed by the treatment of insulin (0.5 nM) for 15
minutes. After treatments, cells were then harvested and western
blot analysis was performed to detect the protein level of ERK,
and total and phosphorylated levels of PKR and IRS1. (B) In
HepG2 cells, the forward transfection of empty vector pCMV6-
XL5 (pCMV6) or plasmid containing PKR cDNA sequence
( p C M V 6 - h P K R )w a sp e r f o r m e da n dt h ec e l l sw e r et h e nt r e a t e d
with the pharmaceutical inhibitor of ERK, PD98059 (PD98059,
50 uM) or DMSO, vehicle of PD98059, for 1 hour, followed by
the treatment of insulin (0.5 nM) for 15 minutes. After
treatments, cells were then harvested and western blot analysis
was performed to detect the total and phosphorylated levels of
IRS1 and PKR.
Figure 7. Essential signaling network of insulin signaling and
its feedbacks. The direct interaction between PP2A and AKT is
removed. The ERK feedback is removed, together with the downstream
factors in the ERK pathway that do not have an effect on the regulation
of insulin signaling.
doi:10.1371/journal.pone.0008040.g007
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Figure S6 Robust dynamics against noise. The noise is
represented by the variation in the distribution of initial states
for each component. Colors on the distribution: light grey: control
state (1), dark grey: higher than control (2), black: lower than
control (0). Perturbations and simulations are based upon the
essential pathway model that excludes the ERK pathway, with
uniform distributed initial state for each component.
Found at: doi:10.1371/journal.pone.0008040.s006 (0.29 MB TIF)
Figure S7 A small regulatory network with catalytic activation/
inhibition. S is the stimulator (input) of the system. Upon
stimulation of S, A activates B. There is a negative feedback from
B to A. Simulation results of a kinetic model, a qualitative
(Boolean) model with asynchronous or synchronous updating are
shown.
Found at: doi:10.1371/journal.pone.0008040.s007 (0.23 MB TIF)
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